Mitchell Keegan

Vice President, Drug Development

Dr. Keegan has served as our Vice President, Drug Development since September 2009.  From April 2008 until September 2009, Dr. Keegan served as our Executive Director, Drug Development.  From April 2005 to March 2008, Dr. Keegan was employed by Gloucester Pharmaceuticals, as Senior Director, Drug Development. From December 2001 to April 2005, Dr. Keegan was employed by Combinato Rx where from December 2001 to December 2003 he served as Team Leader, Pharmacology and from December 2003 to April 2005 as Director, Pharmacology.  From January 2001 to December 2001, Dr. Keegan worked as a Study Director, employed by Toxikon.  From October 1998 to January 2001 Dr Keegan served as Research Fellow in Medicine at Harvard Medical School/Joslin Diabetes Center. Dr. Keegan holds a Ph.D. from the University of Western Sydney, Australia and a B.S (Hons) from the University of Sydney, Australia.